In a 3xTg AD mouse model and in human AD patients, hyperphosphorylated retinoblastoma protein, a marker for G1/S transition, co‐localized with hyperphosphorylated tau, linking aberrant cell cycle progression with tau pathology (Hradek et al., 2015). Here, MAPT is linked to Alzheimer disease.